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T e meets of passive smoking om emit heart disease are
reviewed. Short-term a of 20 min to 8 h result in
. platelet sensitivity and decreased ability f the hew to
receive mW proem oxygen . Longer term exposure results in
plaque buildup and adverse effects on blood cholesterol . Ile
available epidem is reviewed, and It is concluded that
passive smoking havases the coronary death rate among U.S .
never smokers by 20% to 70% . The newest Environmental
In August 1992 the Council on Cardiopulmonary and Critical
Care of the American Heart Association published its posi-
tion statement (1) on environmental tobacco smoke and
cardiovascular disease and "concluded that [environmental
tobacco smoke] is a major preventable cause of cardiovas-
cular disease and death ." Their conclusion was based on
their own investigation and on two earlier reports by Glantz
and Parmley (2) and Steenland (3) . The report by Glantz and
Parmley presents an excellent overview of the epidemiology,
physiology and biochemistry of the link between passive
smoking (the exposure of nonsmokers to environmental
tobacco smoke) and heart disease . The Steenland report
presents a risk assessment based on epidemiology and
concludes that environmental tobacco smoke causes an
estimated 35,000 to 40,1 ischemic heart deathslyear in the
United States. This confirms an earlier risk assessment by
Wells (4). However, as noted later, these estimates may be
low .
The present report reviews briefly the principal evidence
connecting passive smoking with ischemic heart disease,
including the most recent data . In addition, steps will be
outlined that practicing physicians can take to protect their
patients from environmental tobacco smoke exposure.
Biologic Plausibility
Active smoking is a well known cause of heart disease (5) .
There is clear evidence of dose response, and the chemicals
in mainstream smoke thought to be most important in
causing heart disease, namely, carbon monoxide, nicotine
and polyaromatic hydrocarbons (6), are also present in
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01594 by the American College of Cardiology
action Agency p ores for est' ting deaths from passive
smoking, when applied to the epidemiologic results on heart
passive sm. ' , indicate that in 1985 an estimated
62, ischemle heart disease deaths In the United States were
associated with exposure to environmental tobacco smoke . Clini-
c are advised to counsel their patients to avoid tobacco smoke
at home, at work and in transportation settings .
(f Am Cold Cardiol 1994,24 .546-54)
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environmental tobacco smoke, although they are diluted
considerably by the ambient air. Logically, therefore, one
would expect environmental tobacco smoke exposure to
result in heart disease but at a level lower than that from
active smoking. The same argument is used by the U .S .
Environmental Protection Agency in their recent report (7)
on lung cancer from passive smoking, that is, that the
chemical similarity between mainstream tobacco smoke and
environmental tobacco smoke means that lung cancer from
environmental tobacco smoke is biologically plausible .
However, an analysis of the epidemiology is required before
the level of risk can be estimated .
There is one important difference between lung cancer
and heart disease insofar as passive smoking is concerned .
With lung cancer, the potentially fatal health effect results
only from long-term exposure, perhaps >20 years, whereas
with heart disease, the potentially fatal effects are not only
long-term and chronic but short-term and acute as well.
Acute heart effects from passive smoking . The acute ef-
fects of passive smoking on the cardiovascular system can
occur from exposures of 20 min to 8 h. They are covered in
detail by Glantz and Parmley (2) . Suffice it to say here that
these effects consist of t) a decrease in platelet sensitivity
that leads to greater platelet aggregation and increased risk
of coronary thrombosis, and 2) an increase in oxygen de-
mand by the heart at a time when oxygen supply is decreased
and the heart's ability to process oxygen is also decreased .
The evidence for increased platelet sensitivity comes
from the laboratories of J . W. Davis in Kansas City and
H. Sinzinger in Vienna. The blood of smokers has a greater
tendency to coagulate than the blood of non-smoke-exposed
nonsmokers . This is expressed as a lower platelet sensitiv-
ity . Davis et al. (8,9) showed that exposure of nonsmokers
for 20 min to environmental tobacco smoke in an elevator
lobby of a hospital drove their platelet sensitivity more than
half way (-60%) toward the active smoker level . Burghuber
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et al . (10), in Sinzinger's laboratory, found that nonsmokers,
when exposed 20 min to a more intense level of environmen-
tal tobacco smoke (30 cigarettes smoked in an
18_M3
room)
lost -80% of their platelet sensitivity advantage over smok-
ers. In both cases the platelet sensitivity returned to normal
shortly after the exposure to environmental tobacco smoke
had been terminated . However, Sinzinger and Virgolini (11)
found that after repeated exposures of nonsmokers to envi-
ronmental tobacco smoke at the same intensity, their base-
line platelet sensitivity moved much closer to that of the
smokers. In addition to their work on platelets, both labora-
tories found an increase in endothelial cell carcasses in the
blood of nonsmokers who had experienced short-term expo-
sure to environmental tobacco smoke, an indication of
arterial wall damage . The experiments by Davis et al . (12)
with sham cigarettes indicate that most of this platelet and
cell count effect arises because of the nicotine in tobacco
smoke.
The other acute effect that environmental tobacco smoke
has on the heart is a complex of effects driven largely by the
carbon monoxide in the smoke . Again, the reader is referred
to Glantz and Parmley (2) for a detailed discussion and a
complete list of references . Another good discussion of the
effects of low levels of carbon monoxide an cardiovascular
function is the editorial by Dwyer and Turino (13) . As noted
in the 1986 Surgeon General's report on passive smoking (14
[Table 10, page 151]), carbon monoxide levels in typical
environmental tobacco smoke atmospheres range from I to
-50 ppm, with many values in the 3- to 25-ppm range . The
concentrations of carbon monoxide when environmental
tobacco smoke was present were often two to three times the
concentration when environmental tobacco smoke was not
present. Exposure to 10 ppm of carbon monoxide over 8 h
results in 1 .4% of the blood hemoglobin being tied up as
carboxyhemoglobin (14), and 100 ppm leads to an equilib-
rium value of 14% (12) . In most human experiments with
carbon monoxide or environmental tobacco smoke, the
exposure results in nonequilibrium carboxyhemoglobin lev-
els of 2% to 4%, which fall within a range that would be
attained by equilibrium exposure to many environmental
tobacco smoke atmospheres .
The reaction of carbon monoxide from environmental
tobacco smoke with blood hemoglobin results directly in a
reduction of the ability of the blood to transport oxygen .
Thus, the heart rate for a given level of activity must
increase to maintain the same oxygen supply . There is also
evidence (2,13) that carbon monoxide attacks and binds to
some of the proteins and enzymes, such as myoglobin
cytochromes (including cytochrome P-450), catalase and
peroxidase, some of which are essential to myocardial
mitochondrial respiration . The overall effect of these carbon
monoxide- or environmental tobacco smoke-induced
changes is reduced exercise ability both in patients with
coronary artery disease and in young healthy subjects (2) .
This conclusion is confirmed by recent work of Leone et al .
(15) who conducted exercise tests in healthy and postmyo-
cardial infarction subjects in environmental tobacco smoke
atmospheres controlled to 30 to 35 ppm of carbon ruonoxide .
There is also evidence from animal models that both short-
and long-term environmental tobacco smoke exposure re-
sults in reduced cardiac mitochondria) respiration (2,16) .
Lung-term effects from passive smoking . In the previous
discussion on platelets it was stated that short-term exposure
to environmental tobacco smoke results in increased endo-
thelial cell carcasses in the blood . This indicates damage to
the arterial endothelium, which is thought to be the initiating
step in the development of atherosclerotic plaques (17) .
Glantz and Parley (2) present evidence from animal stud-
ies, as of 1990, indicating that both increased platelet aggre-
gation and the presence of carcinogenic agents can increase
plaque formatiain. These experiments, mostly in chickens,
pigeons or mice, indicate that carcinogenic polyaromatic
hydrocarbons, such as benzo-a-pyrene, tend to concentrate
in the lung and heart, and they accelerate the growth of
arterial plaques . A recent report by Zhu et al . (18) states that
exposure of New Zealand male rabbits for 10 weeks for
6 Idday to environmental tobacco smoke that contained
either 18 ppm of cartann monoxide (definitely in the range of
many environmental tobacco smoke exposures) or 60 ppm of
carbon monoxide (accelerated exposure) resulted in larger
lipid lesions in the aortas and pulmonary arteries than was
the case for unexposed rabbits . The mean percent athero-
sclerotic involvement from the aortas was 30% for thz-
control animals, 36% for the low dose group and 52% for the
high dose group . For the pulmonary arteries, the corre-
sponding percents were 22%, 291/1c and 45 1A. There was also
evidence of greater platelet aggregation in the exposed
groups than in the control group . Penn and Snyder (19)
studied plaque formation in the abdominal aortas of cocker-
els exposed to environmental tobacco smoke that contained
35 ppm of carbon monoxide . Although they found no signif-
icant increase in the number of plaques formed in exposed
compared with nonexposed cockerels, the size of the aver-
age plaque was increased -5096 .
In humans, Howard et al . (20), using ultrasound measure-
ments, found that carotid artery wall thickness was progres-
sively increased on going from nonexposed never smokers to
environmental tobacco smoke-exposed never smokers to
former smokers and finally to current smokers . The differ-
ence in wall thickness between the environmental tobacco
smoke-exposed group and the nonexposed group was sta-
tistically significant and increased as the hours of reported
exposure to environmental tobacco smoke increased . Envi-
ronmental tobacco smoke also appears to have an effect on
cholesterol in nonsmokers . Several investigators (21-23)
have found in studies on children that exposure to environ-
mental tobacco smoke from their parents resulted in higher
total cholesterol levels in the blood and lower levels of high
density cholesterol
. More recently White et al, (24) found
similar results in adults exposed to environmental tobacco
smoke in the workplace
. This is despite the finding by Le
Marcband et al . (25) that nonsmoking wives and presumably
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T 1. Epidemiologic Studies of Passive Smoking and Ischemic Heart Disease Among Never Smokers
Population
No. of or Control
Study
Cases Subjects
Study Locale Frame Type F M
F M End Point Nonfatal Adjustment Factor Assigned$
Butler (27) California 1976-1 2 Pros . 150t 75$ 12,866 1,4
IH) f A 4
Dobson et al. Australia 1988-1969 CIC 160 183
532 293 MI or [RD f+nf A, PIHD 3
Time
(28)
CdeAnd et al. California 1974-1983 Pros .
19 - 695 IHD f A, B, C, P11D, W, MS I
(29)
He et al . (30) China
He et al. (31) China 1 1992 C/C 67
Hirayama (32) J 1966-1981 Pros. 495
Hole et al . (33) Scotland 1973-I Pros. 551
92
Humble et al . Georgia 1960-1980 Pros. 76
(34)
Jackson (35) New
Zealan5
Lee et al . (36) England
Sandler et al . Maryland
(37)1
Svendsen et al . USA
(39)
Total
1980s CC 34 68
-- MI or CA
of
-1988 C/Cf
1979-1982 C/C
1963-1975 Pros.
1973-1982 Pros .
9
It
77
2,233
13
69#
898
®1 - highest tier assignment
. tLog mean of Adventist Health Smog cohort and spouse pairs (27) . $Adventist Health Smog cohort only, no spouse pair data
(27). §Updated through December 1988 by Hole DJ, private communication, January 1990 . IlNumbers contain some people later found not to qualify for inclusion
in the analysis . ¶update of earlier report by Helsing et al . (38) . #Includes the 13 fatal events . A = e; AHD = arteriosclerotic disease ; AL =alcohol; B a blood
pressure or hypertension ; C = cholesterol ; CA - coronary arteri phy; C/C = case control ; CHD = coronary heart disease ; CVD = cardiovascular disease ;
D - diabetes; E = education ; ECG - abnormal electrocardiogram ; f - fatal; F - female ; FH = family history of hypertension ; FIHD = family history of ischemic
heart disease ; HS = housing ; IHD - ischemic heart disease; M = mate ; MI m myocardial infarction : MS = marital status; of - nonfatal; 0 = occupation; P
personality type ; PIHD = personal history of ischemic heart disease; Pros . = prospective ; R = race ; RE = residence ; SS = social status ; W = weight or body
mass index ; X = exercise .
children of smokers have less cholesterol in their diets than
wives of nonsmokers. Another indication of the striking
t of environmental tobacco smoke on the blood is found
in the work of Tribble and Fortmann (26) who measured
plasma ascorbic acid levels
. Passive smokers exposed to at
least 20 h/week of environmental tobacco smoke had a
statistically significant reduction of ascorbic acid levels that
was 65% of that experienced by active smokers .
In summary, as with active smoking, there is ample
biologic evidence, including human evidence, that exposure
to typical levels of environmental tobacco smoke can cause
a buildup of arterial plaque and thus lead to heart attacks .
Also there are acute effects related to the nicotine and
carbon monoxide in environmental tobacco smoke that may
be important mechanisms through which environmental to-
bacco smoke causes adverse heart effects .
Epide>niology
The available epidemiology associating passive smoking
with heart disease is displayed in Table 1 (27-39)
. With 12
studies and 3,131 cases, it is almost as extensive as that
associating passive smoking with lung cancer (30 studies and
21 62 61 CHD
28 112 123 MI
41 318 133 IHD
370 14.873 4,162 AHD
Fatal or
135 - ME or CA of
91,540 -- 1113 f
651 1,784 671 IHD f
46 1,784 671 Angina, ECC of
513 -- CVD f
1,245 MI or IHD f
1,245 MI or ECG f+nf
A, B, C, D, x, a, RE, 0,
FH, FIHD, AL
A, E . C, K, E, G, NIS . P, W I
A 4
A. B . C, SS, W 2
A, E . C, SS, W
A, E . C, SS, W 2
f A. SS. PIHD
of A, SS, PIHD
of A. MS
f A. MS, E, HS
A, B, C, PIHD . W, AL,
A, B, C. PIHD . W, AL, E
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3,083 cases [7]) . There is no heart study of the quality of the
large Fontham et al. (40) study on lung cancer, which was
designed specifically for passive smoking and where data
from five U.S. centers were combined. In that study both
patients and control subjects provided serum samples for
cotinine assay to eliminate smoker misclassification effects .
However, correction for smoker misclassification bias is
much less for passive smoking and heart disease than for
passive smoking and lung cancer because the relative risk
for heart disease from active smoking is so much less than
for lung cancer. Another aspect that some investigators
would regard as a strength is that the proportion of studies
that are prospective (vs. case control) is much higher here (7
of 12) than in the lung cancer studies (4 of 30) (7). We have
no epidemiology that deals specifically with acute effects, in
which the subjects were asked whether or not they were
exposed to environmental tobacco smoke during the hours
immediately before their heart attacks . Whatever acute
effect there is is included with the chronic effects in the
recorded fatal and nonfatal coronary events .
Each study in Table 1 is assigned a quality tier ranking of
I to 4 based on the number and importance of the heart risk
factors for which corrections have been made . The impor-
JACC Vol . 24, No
. 2
August 3994:546-54
Table 2 . Relative Risks Associating Ischemic Heart Disease Morbidity With Passive Smoking
Dose
My
	
(95% CI)
Smoker Misclassification Weight
Tier
Response*
Women
He et a]
. (30) ISO (0.63-3 .6)
He el al . (31) 2 .89 11 . 11-7 .341
Combined 2 .03 (1 .08-3 .83)
Hole et al . (33) 1 .13 (0 .69-1 .86)
Combined 1 .41 (0.95-2 .09)
Dobs©n et al
. (28)y 2 .46 (1 .47-4 .13)
Jackson (35) 2 .7 (0.57-12 .3)
Lee et al. (36) 0.93 (0 .54-1 .62)
Combined 1 .51 (1 .16-1 .97)
Men
Svendsen et al. (39) 1 .61 (0 .96-2 .71)
Dobson et al, (Ml 0 .97 (0 .5(1-1 .86)
Jackson (35) 1 .03 (0 .27-3 .9)
Lee 114 (0.59-2 .59)
Combined
1 .28 (0.91-1 .81)
Women and men
Combined
Combined
Combined
Adjusted RR,
137 (1
A
8-2
A5)
IAS (1 .08-2,02)
1 .42
Adjusted RR
P
Corrected for
ISO
190
2.04
1)0
139
2 .48
2 .71
0.91
130
1 .43
0-90
0.92
1 .19
IAN
1 .65
140
137
tant potential confounders were considered to be age, hy-
pertension, cholesterol, weight, social class, marital status,
personal history of heart disease, exercise and history of
diabetes. Studies that corrected for six of these nine or five
plus two others not listed were assigned to tier 1 ; those that
corrected for four of the nine or three plus two not listed
were assigned to *; , cr 2 ; for two of the nine, or one plus two
others, tier 3 ; and for fewer than tier 3, tier 4 . The size of the
studies was accounted for in the statistical analysis in Tables
2 and 3. Other quality features of the studies were thought to
be too subjective to use in the quality ranking .
Because it comprises almost half of the total cases, the
Sandler et al. (37) study deserves special attention . It is a
prospective mortality study in which 98% of the households
in a western Maryland county were enrolled . Information on
cigarette, cigar and pipe smoking habits for each household
member age 16.5 years or older was recorded . An adjust-
ment was made to the base population for those leaving the
county during the 12-year follow-up . Because there were
only 2% blacks, the analysis was restricted to whites . Death
certificates were matched against those enrolled for primary,
contributing and underlying causes of death . To determine
environmental tobacco smoke exposure, Sandier et al . con-
structed a household smoking score based on the smoking
contribution of all persons living in that household other than
the subject . Information was also obtained on age, marital
status, years of schooling and quality of housing, all of which
were found to have important effects on death rates and
smoke exposure status . Hence, relative risks were adjusted
Statistical
11
4.4
9.5
15.6
25.1
114
1 .6
12 .6
53 .7
23 .8
19-4
86.2
Quality
1X 231 517, 1167
Significant trend
I only
2 1 .07, 1 .69
1+2
3
3
3
I+2+3
14 .3 1 1 .20, 1 .75
8.9 3
12 3
7.1 3
32.5 1+2+3
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*For He et al . Oft crude RR, for exposures
in cigarette-years, 1-199, 200-399,400-599, 600+-,
for
Hole et al, (33), cigarcitesiday, <15, 15+
; for Svendsen
et al . (39), cigarettes/day, 1-19,20+ . *Some fatal cases are included, but the proportion is believed to be s mall . CI = confidence interval, RR,, = passive smoking
relative risk or odds ratio adjusted for the factors listed in the next to last column of Table 1 . Note added in proof: A further morbidity study of men and
women
in Italy has come to the author's attention (La Vecchia C, et al . Lancet 1993 ;341 :505-61 [letter]) . Their adjusted RR, far highest exposure is 1
.30 (95% Cl 0 .50-3 .40) .
Inclusion of their results lowers somewhat the combined morbidity RR,, but would not change the mortality risk assessment (see Table
4) or the conclusions .
for these items, but, unfortunately, no data were available
for the other six important heart risk factors in our list .
Morbidity studies . The adjusted relative risks and 95%
confidence intervals for studies of nonfatal coronary events
are shown in Table 2 . In two studies (28,39), some fatal
events are included, but the proportion is or is thought to be
small. For the case-control studies, odds ratios are assumed
to be valid estimates of relative risks . The studies are
arranged by the tier levels noted in Table 1 .
Each of the relative risks is corrected for misclassification
of smokers as never smokers using the method that was used
by the Environmental Protection Agency (EPA) in its lung
cancer report (7 [Appendix 131) . This method relies on
observed gender-specific misclassification rates for never
smokers obtained from cotinine measurements or repeated
questionnaires. This bias arises because smokers tend to
marry smokers
. Thus, "never smokers" who are really
misclassified smokers are more likely to be found in the
exposed never-smoker category than in the nonexposed
category
. The result is an overestimation of the relative risk
unless the passive risk approaches or exceeds the active
smoking risk
. The overestimation can be important in lung
cancer studies, where the relative risk of ever smokers
(those who have smoked at some time in their lives) versus
all never smokers is higher (-8
.0) but is less important in
heart disease studies, where the corresponding relative risk
for ever smokers is 1 .7
. Corrections to the relative risks for
women are very small
; for men the corrections are larger
because the proportion of ever smokers is much higher,
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Table 3.
Relative Risks Associating Ischemic Heart Disease Mortality With Passive Smoking
Adjusted RR,
Adjusted RR, Corrected for Statistical
Quality Dose Trend
Study (95% CI)
Smoker Misclassification
Weight Tier Response"
(p value)
Women
Garland ei al . (29) 2
.7 (0.7-10.5)
2 .73
Hole et al. (33)
1 .65 (0.79-3.46)
1 .63
Humble et al. (34)t 1 .59 (0
.99-2.57) 1 .59
Combined 1
.68 (1 .14-2.47) 1 .67
Jackson (35)
5.8 (0.95-35.2)
5 .8
Sandler et al
. (37) 1.19 (1,04-1
.36) 1.18
Combined 1 .25 (1
.10-1 .41) 1.24
Buller (27) 1
.29 (0.94-1 .77) 1 .29
H.irayama (32)
1 .15 (0 .93-1 .42)
1 .15
Combined
1 .23 (1 .11-1 .36)
1,22
Men
Svendsen et a1 .132) 2,23 (0 .72-6
.92) 2 .62
Hole et al . (33)
1 .73 (1,01-2.96)
1 .75
Combined 1 .81 (1 .11-2 .96)
1 .89
Jackson (35) 1 .1 (0 .23-5 .2)
1 .06
Sandler et al . (37) 1
.31 (1 .05-1 .64) 1 .21
Combined
1 .38 (1 .13-1 .69) 1 .30
Bailer (27) 0.54 (0,30-0.96)
0 .54
Combined 1 .25 (1 .03-1 .51)
1 .19
Women and men
Combined 1 .73 (1 .28-2 .34) 1 .75
Combined 1 .28 (1 .15-1 .42) 1 .25
Combined 1 .23 (1 .12-1 .35)
1 .21
U.S . women and men
Combined 1 .75 (1 .15-2 .66) 1 .79
Combined 1 .25 (1 .12-1 .40) 1 .22
Combined 1 .22 (1 .10-1 .35}
1
.20
leading to more misclassified smokers. The corrected risks
for each study are shown because many investigators still
worry about the impact of this bias .
The statistical weight (wt) for each study is the inverse of
that study's variance and can be calculated from chi values
and the passive smoking relative risk (RR) as wt ° (chi/In
RRp)2 , orfrom the 95% confidence limits (CL) as wt ®1 .962/(In
CL - in RR~)2 . The combined relative risks are the weighted
tog means of the appropriate individual values (7). To get
some measure of dose response for those studies where data
are available, the relative risk estimates for successive
exposure levels are shown in the last column along with p
values for trend, if available, Three of the six studies on
women show some evidence of dose-response versus one of
four among the studies on men . As the EPA report (7) and
earlier studies have found, pooled data on passive smoking
health effects on men are not as consistent as data on women
because male never smokers are subject to more miscella-
neous environmental tobacco smoke exposure, referred to as
"background," relative to spouse exposure than is the case for
female never smokers (41) . Pooled results for men and women
7ACC Vol. 24, No . 2
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2 .1 I
3,0, 2 .25
7
.0
2 2 .09, 4 .12
16.9 2 1 .02, 2 .11, 2 .55
26.0 1 + 2
1 .2 3
213 .5 3 1,20 . 1 .27 < 0,005
240.7
1+2+3
38 .3 4 1 .12, 1 .50
85 .8 4
1
.08, 1
.30
364 .8 All 4
3 .0 1 0.90 .3 .21 0 .04
13 .3 2
16.3
1 + 2
1 .6
3
77
.3 3
1 .38, 1 .25
95 .2 1+2+3
11 .4 4 0.41, 0 .61
106 .6 All 4
42 .3
1 + 2
335 .9 1+2+3
471 .4 All 4
22 .0 1 + 2
312 .8
1+2+3
362 .5
All 4
"For Garland et al . (29)
exposure
to ex- and current
smokers ; for Hole et a(. (33)
.
RR
P
for 33 cases . adjusted to age only, exposure to a 15, j5+ cigaretteslday ;
for Humble et al. (34), exposure to a 10,10 to 20,21 + eigarettesiday ; for Sandler et al . (371 . 1-5 .6+ on a smoke exposure score, Where 6+ is approximately equal
to 10+ cigarettes/day of current exposure (trend data are from Helsing et al . (381, where RR, is higher) ; for Butler
(27),
ex- or I to 10, current or II+
cigarettes/day
;
for Hirayama (32), ex- plus I to 19, 20+ cigarettes/day ; for Svendsen et al . (32) .1 to 19, 20+ cigaretteslday . tExposure to current smokers only .
Abbreviations as in Table 2 .
combined are also shown. In general, the pooled relative
risks decrease as lower tier studies are added to the analysis .
M ity studies. The results of the mortality studies are
shown in Table 3, where we have more cases, 2,336, than we
had for the morbidity studies, and the pooled risks show
good statistical significance throughout the table . Five of the
seven studies in women show evidence of dose response, but
only two of the five studies in men show such a trend . As
with the morbidity studies, the relative risks decline as the
lower tier studies are added to the analysis . This strongly
suggests that a number of heart risk factors affect the results
and need to be adjusted for if meaningful passive risks are to
be obtained. Omitting the large Sandler et al . (37) study from
the analysis has only a minimal eff:.ct on the combined point
estimates. The combined relative risks for the U .S. mortality
studies are quite similar to those for the worldwide studies,
and the risks for the mortality studies are consistent with
those for the morbidity studies .
From the epiden-dology, one can conclude that there
appears to be a 20% to 70% increase in ischemic heart
disease risk that is associated with exposure to spousal or
JACC Vol . 24 . No . 2
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household environmental tobacco smoke and that this in-
crease in risk is not explained by misclassification of smok-
ers as nonsmokers or by the other heart risk factors .
Mortality Risk Assessment
Three risk assessments of ischemic heart deaths in the
United States from passive smoking have so far been made .
They are Wells (4), 32,000 deaths/year; Glantz and Parmley
(2), 37,000 deaths/year (this is the Wells estimate 141 when
fully corrected for background environmental tobacco
smoke); and Steenland (3) who used a somewhat different
procedure to arrive at 35,0 to 40,000 deathslyear. All three
of these assessments were based on estimates of never-
smoker heart death rates and the estimated population of
never and ex-smokers . Never-smoker death rates that are
representative of the whole United States are difficult to
estimate . Previous risk assessments have depended on rates
from the two large American Cancer Society studies (3,4),
the U .S. veterans (3), Seventh Day Adventists (3) and the
Nurses Health Study (3). The never-smoker death rates
calculated from these specialized cohorts may be lower than
the U.S. average. In the recent EPA report on lung cancer
and other respiratory diseases (7), a different methodology
was used based on total lung cancer deaths, including those
of smokers . This methodology will be applied here .
The EPA method (7), developed by K. G. Brown, starts
with the total number of lung cancer deaths, which for
women was 38,000. These deaths are then allocated, using
the passive and active smoking relative risks, among four
categories : 1) deaths from spousal or household environmen-
tal tobacco smoke among never smokers and >5-year ex-
smokers ; 2) deaths from background environmental tobacco
smoke, including workplace exposure, if any ; 3) deaths from
ever smoking less those from environmental tobacco smoke
among ?5-year ex-smokers ; and 4) deaths from non-
tobacco-related causes . (See pages 6-8 to 6-21 in ref . 7 for
a description of the method.) The EPA made an estimate of
environmental tobacco smoke-attributable lung cancer
deaths for never-smoking women and then applied the
incremental female environmental tobacco smoke death
rates to never-smoking males and 5-year
ex-smokers of both
genders because good passive smoking data were not avail-
able fer the latter categories .
In our heart case, we will start with the known total
ischernic heart disease deaths for 1985, namely, 251,000 for
women and 285,800 for men (44) . As noted in the previous
section, the relative risks appear to increase as the number
and importance of heart risk factor adjustments increase .
Accordingly, we will calculate deaths for risks from tiers
1 and 2 and from tiers 1, 2 and 3, but the latter will be
designated the preferred case because of more deaths and a
tighter confidence interval . Also, unlike the problem for lung
cancer, the male ischemic heart disease relative risk data are
similar to the female data . Therefore, we will assume that
never-smoking men and women both have corrected passive
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smoking ischemic heart disease relative risks (RR p,) of 1 .22
for the preferred case (tiers 1 to 3) and 1
.79 for tiers I and 2
based on the combined corrected U .S. data in Table 3. For
>5-year ex-smokers we have followed the EPA procedure
(7) and have assumed that their incremental death rate from
passive smoking and isch~muc heart disease is the sane as
for never smokers . It is known that an ex-smoker's cardiac
risk drops more rapidly after smoking cessation than does
his or her risk for lung cancer (45), but this has no influence
on the passive smoking risk analysis because we are treating
the passiv- smoking exposure as an add-on effect for ex-
smokers .
There are two other key variables that affect the risk
assessment : 1) the ischemic heart disease relative risk for
ever smokers relative to all never smokers (RR,,,,), which we
assume to be I A for both genders (5) ; and 2) Z, the ratio of
environmental tobacco smoke exposure from spousal smok-
ing plus other environmental tobacco smoke exposures to
exposure from other sources alone . The Z factor is a
measure of the background environmental tobacco smoke to
which most people in the United States are exposed . It is
estimated by comparing current cotinine concentrations in
the body fluids of never smokers exposed to spousal smok-
ing to the same cotinine measurement for those who are not
so exposed (cotinine is a metabolite of nicotine with a longer
half-life) . It is further assumed that the increased ischemic
heart disease mortality risk from environmental tobacco
smoke among never smokers is directly proportional to their
cotinine assay . In general, a lower Z means relatively more
background environmental tobacco smoke exposure, a
higher relative risk estimate when corrected for background,
and a higher number of calculated deaths . The EPA, in their
lung cancer report (7), used Z r (for women) = 1 .75 based on
five U .S . studies. We have chosen a more conservative
value of Z f = 2.6 based on the median value for cotinine for
the never-smoking women in the Fontham et al . (-',D) study,
which is the largest U .S. passive smoking)[ung cancer study
based on five population centers largely in the southern part
of the United States, where most of the U .S. studies on heart
disease and passive smoking are based . Men are thought to
be exposed to more background environmental tobacco
smoke than women. Cummings (41) found, for a northern
United States location, Z = 1 .55 for women and 1 .27 for
men
. Using the ratio of Cummings, we have assumed Z (for
men) = 2.6 x (1 .27/1 .55) = 2.1 .
Other important variables, which are the same for heart
disease estimates and lung cancer estimates, are taken
directly from the EPA report (7), namely, U
.S . population
a35 years old, 58 million women and 48 million men ;
ever-smoking prevalence (p i ) of 44.3% for women and 72
.8%
for men; never-smoker spousal passive smoking exposure
(p2), 60% for women and 24% for men
; ?°5-year ex-smoker
population 8 .7 million women and 15
.0 million men; and the
fraction of these ex-smokers exposed to spousal smoking,
77% for women and 41% for men .
The calculated numbers of deaths are shown in Table 4
.
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Table 4. Estimated Annual Ischemic Heart Disease Deaths in U
.S. Nonsmokers Attributable to Passive Smoking, 1985
: Effects of
Selected Variables
RRN =
passive smoking relative risk from spousal exposure, unadjusted for background exposure but corrected for smoker misclassification ; RR,.,, = ever
smoker relative risk versus all never smokers ; Zr (Z„,)
= ratio of environmental tobacco smoke exposure from spousal smoking plus other sources to exposure
from other sources alone, for women (men).
The preferred case, where the passive relative risk, RR p,, is
1.22, the active smoking risk, RR, is 1
.7, the Z ratio for
women, Zr , is 2.6, and that for men, Zm , is 2 .1, yields an
estimated total number of passive smoking ischemic heart
disease deaths in the United States of 62,000 for 1985 . The
calculated deaths when data from tiers I and 2 only are
included are 183,000 . The estimated numbers of deaths are
very sensitive to RR p ,, RR
.,
and Z. Table 4 shows the effect
of varying these variables . However, none of the estimates is
<49,000 .
The estimated annual deaths shown in Table 4 are con-
siderably higher than the 32,000 to 40,E noted in earlier
studies . One reason is that the never-smoker death rates that
we derive from the known total ischemic heart disease
deaths in 1985 are higher than the never-smoker death rates
assumed in the earlier risk assessments. Another reason is
their use of Z = 3.0 based on early work in England (45),
whereas we have used the lower U .S. values .
An estimated allocation of ischemic heart disease deaths
among the four categories for the preferred case (lop row,
Table 4), broken down into never smakers, 5-Year ex-
smokers and other ever smokers, is shown in Table 5 . The
percents for each category of the 536,800 total U .S. ischemic
heart disease deaths are 4 .5% for exposure to spousal
tobacco smoke, 7 .0% for exposure to background tobacco
smoke, 34 .5% for ever smoking and 54 .0% for nontobacco
causes. Thus, environmental tobacco smoke is estimated to
cause (4.5 + 7 .0)134.5 = 33% as many cardiac deaths as
those caused by active smoking. The relative cardiac risks
for passive and active smoking for women, 1 .22 and 1 .7,
become 1 .41 and 2 .23 when the comparison group for both is
never smokers with no environmental tobacco smoke expo-
Table S. Passive Smoking Mortality for Ischemic Heart Disease by Attributable Sources for
*Includes ever smoking effects on >5-year ex-smokers, thought to be small
.
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Variation
RR PC RRSm
Z f
Estimate,d Deaths
Zm Women
Men Both
Preferred case (tiers I + 2 + 3)
1 .22
1 .7 2 .6 2 .1 33,198
28,714 61,912
Tiers I + 2 only
1 .79
1 .7 2 .6
2.1 91,551 91,253 182,804
Preferred case with
Lower Zr
1 .22
1 .7 2 .1 2.1 40,677 28,714
69,391
Higher RR,,,
1 .22
2.3 2 .6 2.1
27,599 22,270 49,869
Higher Zm
1
.22 1 .7 2 .6
2.6 33,198 22,145 55,343
Lower RR,
1 .18 1 .7
2 .6 2.1 27.750 23 .710 51,460
United States, 1985
Smoking and
Exposure Status
Spousal
Environmental
Tobacco
Smoke
Background
Environmental
Tobacco
Smoke
Ever
Smoking
Nontobacco
Causes
All
Causes
Never smokers
Women 12,444 12,962 81,309 106,714
Men 2,583 9,783 39,130 51 .496
Both 15,207 22,745 120,439 158,211
?$-year ex-smokers
Women
4,301 3 .491 21,896 29,688
Men 5,110 11,239 44,957
61,306
Both 9,411 14,730 66.853 90,994
Other ever smokers*
Women
71,826 42,771 114,597
Men
113,224 59,774 172,998
Both
185,050 102,545 287,595
Total
Women 16,745
16,453 71,826 145,976 251,tr00
Men
7,693 21,022 113,224
143,861 285,800
Both 24,438
37,475 185,050 289,837
536,800
JACC Vol . 24, No . 2
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sure of any kind (RRO2 and RR01 in the notation of the report
[7] from the EPA) . For men, Qn =w 113 and 11104 1 = 2 .24 .
Thus, the excess risks, 0 .4111 .23 and 0.53/1 .24, exhibit ratios
of 33% and 43%, respectively, for women and men. That
such high ratios between the mortality effects of passive and
active smoking might be biologically plausible is supported
by the dramatic platelet sensitivity effects noted earlier
(passive effects at 60% of smoker level) and the 20% to 50%
increase in lipid lesion area in animals after environmental
tobacco smoke exposure (18,19) .
To summarize, on the basis of the rather thorough meth-
ods of the EPA to calculate deaths from passive smoking,
the cardiac deaths so calculated are 40% to 100%® higher than
those calculated by earlier methods . What is thought to be
the best estimate in Table 4 indicates 62,000 ischemic heart
disease deaths in the United States in 1985 caused by passive
smoking. It is also possible, if more information about potential
confounders can be obtained, that the toll is even higher .
Discussi
The risk assessment used here assumes a "no-threshold"
model. With respect to heart disease and active smoking, the
1983 Surgeon General's report (5 [p . 119]) notes that there is
no evidence to suggest a threshold for the effect, that is, no
safe level of exposure . Likewise, when the relative risks for
ischemic heart disease and passive smoking are plotted
against exposure variables, they trend toward zero risk at
zero exposure with no evidence of a threshold . The "attrib-
utable risk" approach was used in the risk assessment
primarily because the EPA had used it for lung cancer, and
it has been extensively peer reviewed by their Science
Advisory Board . The method is appealing because it does
not rely on estimates of never-smoker death hates .
A base year of 1985 was used to allow direct comparison
with the EPA results (7) on lung cancer and because good
ischemic heart disease death data were available for that
year. Since then many smokers have quit, resulting in less
spousal exposure, and many workplaces and public places
have restricted smoking. A projection to 1994 assuming
(arbitrarily) one-half as much background exposure, a pro-
jected 9% lower heart death rate and spousal exposure
reduced in proportion to the reduction in spousal active
smoking indicates -47,000 environmental tobacco smoke
deaths instead of the 62,000 estimated for 1985. A 14%
increase in population X35 years old offsets to some extent
the reductions in heart death rate and cigarette smoke
exposure. The spousal exposure rates that were used in the
analysis (60% for women, 24% for men) are for exposure to
ex-smokers as well as current smokers and came from the
exposure of control subjects in the U .S . lung cancer studies
in the EPA report (7) . They appear to be appropriate for
1985. They are thought to be more representative than the
somewhat higher exposures among the control subjects in
the U.S. heart studies (65% and 29%), which are dominated
by the large Sandier et al . study (37) .
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The major uncertainty in the ischemic heart disease death
estimates and in whether or not a passive smoking effect
exists arises because of the many other factors that might
cause cardiac disease and death and might confound the
passive smoking effect . Supporting evidence for an effect is
the strong evidence of biologic plausibility, and, as adjust-
ments are made for more cardiac risk factors, the passive
smoking relative risks tend to increase . One factor not
accounted for in our analysis is nicotine from diet sources
that, if present, would result in a falsely high estimate of the
background effect . Domino et al . (47) have published nico-
tine contents of various vegetables, but Repace (48) has
presented an analysis indicating that these amounts would
constitute only 0.7% of the nicotine absorbed by typical
passive smokers . Deaths calculated using the extremes of
the 95% confidence interval values for the relative risk of
1.22 for the preferred case in Table 4 indicate a range of
26,700 to 98,400 deaths/year.
Another uncertainty is publication bias . The author is
aware of two epidemiologic studies -of passive smoking and
heart disease that did not get beyond the abstract stage .
Hunt et al . ([49] and private communication, August, 1987)
in a morbidity study in Utah found an adjusted relative risk
of 2.7 for spouse-exposed, never-smoking women, but there
were only 23 cases. Palmer et al . (50) found a relative risk for
myocardial infarction of 1 .2 for spouse-exposed, never-
smoking women, but they decided that the power was too
low and did not follow up with a published report . Inclusion
of these studies would have little effect on the results . There is
also an early study showing that exposure to cigarette smoke
increases myocardial infarct size in dogs (Prentice et al . [51])
that apparently did not mature into a published report .
Conclusions
Ischemic heart disease appears to be by far the major
mortality risk from passive smoking . There are both short-
and long-term cardiovascular effects from passive smoking.
Practicing physicians would do well to warn their at-risk
heart patients to avoid smoky rooms. Such patients and the
public in general should seek work where no-smoking rules
apply; they should avoid riding in automobiles when others
are smoking; and, if their spouses smoke, it should be
suggested that they smoke outside the home .
Although the case for ischemic heart disease from passive
smoking is well established, a large study, like the Fontham
et al. (40) lung cancer study, where all of the other important
risk factors are controlled for, would be helpful . Also, it
would be useful to have some autopsy research in humans
who have been exposed long term to environmental tobacco
smoke, but who died from causes other than heart disease,
to see whether higher levels of plaque had built up in their
coronary arteries. Some epidemiology on mortality effects, if
any, from very short-term environmental tobacco smoke
exposure would also be helpful .
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